Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 80425-0296

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 80425-0296). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Description (Description)

FDA Label Image

Label 1 (Venlafaxine Er 75mg 80425 0296 01)

Label 1 (Venlafaxine Er 75mg 80425 0296 01)
This is a description of VENLAFAXINE ER 75MG CAPSULE medication. The medication comes in a pack of 30 and has a lot number of XK000X. The expiration date for this medication is 10/31/2025. No further information is available due to the presence of non-English characters in the text.*
FDA Label Image

Label 2 (Venlafaxine Er 75mg 80425 0296 02)

Label 2 (Venlafaxine Er 75mg 80425 0296 02)
The text appears to be a description of a medication called Venlafaxine ER 75mg Capsule, manufactured by Aurobindo Pharm. It comes in a quantity of 60 capsules and is compared to a drug called Effexor XR. The NDC number is 80425-0296-02 and the source NDC is 65862-0528-90. The lot number is XX0OOOKK and the expiration date is 10/31/2025.*
FDA Label Image

Label 3 (Venlafaxine Er 75mg 80425 0296 03)

Label 3 (Venlafaxine Er 75mg 80425 0296 03)
This is a description of a medication called Venlafaxine ER 75mg Capsule, with a quantity of 90 capsules in the package. The package has a National Drug Code (NDC) of 60425-0296-03 and a Source Number of 65862-0528-90. The lot number is KXXUXKNNX with an expiration date of 10/31/2025. There is also a serial number of 000000137301. No other relevant information is available.*
FDA Label Image

Fig 1 (Fig 1)

Fig 1 (Fig 1)
This appears to be a table listing different population subgroups and their respective hepatic and/or renal impairments, genetics, age, gender, and analyte (likely a type of drug or chemical being studied). The table also includes measurements of fold change and confidence intervals. The analyte is mentioned as "velatarie, velatarine" but without context or additional information about what these refer to.*
FDA Label Image

Fig 2 (Fig 2)

FDA Label Image

Fig 3 (Fig 3)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.